| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2007 | ||||||||
|
aminolevulinate dehydratase | 0.556 | 0.615 | 5.6E-05 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2010 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2004 | 2011 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2010 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1 | 0.564 | 0.654 | 1.00 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2008 | 2010 | ||||||||
|
metallothionein 3 | 0.582 | 0.615 | 6.4E-02 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2001 | 2008 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2006 | ||||||||
|
nerve growth factor receptor | 0.477 | 0.846 | 9.8E-02 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 1999 | 2003 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2010 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
sodium voltage-gated channel beta subunit 2 | 0.678 | 0.192 | 1.7E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
pleiotrophin | 0.515 | 0.808 | 7.5E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 | 0.653 | 0.385 | 0.49 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
protein tyrosine phosphatase receptor type Z1 | 0.623 | 0.615 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
ribonucleotide reductase catalytic subunit M1 | 0.552 | 0.692 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
pro-apoptotic WT1 regulator | 0.542 | 0.846 | 9.0E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
proprotein convertase subtilisin/kexin type 1 | 0.548 | 0.615 | 2.7E-09 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
phosphodiesterase 4A | 0.523 | 0.846 | 0.98 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 |